Other names published for TOP2: TOR3, TRF3, DNA topoisomerase 2, YNL088W
TOP2 LITERATURE TOPICS
- Curated Literature
- Genetics/Cell Biology
- Nucleic Acid Information
- Gene Product Information
- Related Genes/Proteins
- Research Aids
- Genome-wide Analysis
- Proteome-wide Analysis
- Other Topics
- Additional Information
TOP2 - Protein/Nucleic Acid Structure (9)
| Reference | Other Genes Addressed |
|---|---|
| Schmidt BH, et al. (2012) Structure of a topoisomerase II-DNA-nucleotide complex reveals a new control mechanism for ATPase activity. Nat Struct Mol Biol 19(11):1147-54 | |
| Hardin AH, et al. (2011) Direct measurement of DNA bending by type IIA topoisomerases: implications for non-equilibrium topology simplification. Nucleic Acids Res 39(13):5729-43 | |
| Schmidt BH, et al. (2010) A novel and unified two-metal mechanism for DNA cleavage by type II and IA topoisomerases. Nature 465(7298):641-4 | |
| Dong KC and Berger JM (2007) Structural basis for gate-DNA recognition and bending by type IIA topoisomerases. Nature 450(7173):1201-5 | |
| Suda N, et al. (2004) The alpha4 residues of human DNA topoisomerase IIalpha function in enzymatic activity and anticancer drug sensitivity. Nucleic Acids Res 32(5):1767-73 | |
| Classen S, et al. (2003) Structure of the topoisomerase II ATPase region and its mechanism of inhibition by the chemotherapeutic agent ICRF-187. Proc Natl Acad Sci U S A 100(19):10629-34 | |
| Heddle JG, et al. (2001) The antibiotic microcin B17 is a DNA gyrase poison: characterisation of the mode of inhibition. J Mol Biol 307(5):1223-34 | |
| Strumberg D, et al. (1999) Molecular analysis of yeast and human type II topoisomerases. Enzyme-DNA and drug interactions. J Biol Chem 274(40):28246-55 | |
| Berger JM, et al. (1996) Structure and mechanism of DNA topoisomerase II. Nature 379(6562):225-32 | |



